Hillstream BioPharma Terminates Agreement with Intract Pharma Ltd, Appoints New Board MemberWASHINGTON, D.C. — On November 20, 2024, Tharimmune, Inc., with its principal executive offices located in Bridgewater, New Jersey, filed a Form 8-K with the
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Hillstream BioPharma’s 8K filing here. About Hillstream BioPharma (Get Free Report) Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell […]
More Stories
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...